Bassam Jeryous Fares
Tracked across 1 events · 6 articles · First seen Jun 30, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Bassam Jeryous Fares is the first author of the systematic review, playing a key role in its execution and interpretation of the mixed findings regarding creatine's efficacy in treating depression.
Jun 30, 2026 · 6 articles
90
Bassam Jeryous Fares led reviewCreatine's Mixed Results...
ERGEN INTELLIGENCE
Track Bassam Jeryous Fares live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard